Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Dissecting the Heterogeneity of Circulating Tumor Cells in Metastatic Breast Cancer: Going Far Beyond the Needle in the Haystack.

Bulfoni M, Turetta M, Del Ben F, Di Loreto C, Beltrami AP, Cesselli D.

Int J Mol Sci. 2016 Oct 24;17(10). pii: E1775. Review.

2.

A Method for Detecting Circulating Tumor Cells Based on the Measurement of Single-Cell Metabolism in Droplet-Based Microfluidics.

Del Ben F, Turetta M, Celetti G, Piruska A, Bulfoni M, Cesselli D, Huck WT, Scoles G.

Angew Chem Int Ed Engl. 2016 Jul 18;55(30):8581-4. doi: 10.1002/anie.201602328.

PMID:
27247024
3.

In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosis.

Bulfoni M, Gerratana L, Del Ben F, Marzinotto S, Sorrentino M, Turetta M, Scoles G, Toffoletto B, Isola M, Beltrami CA, Di Loreto C, Beltrami AP, Puglisi F, Cesselli D.

Breast Cancer Res. 2016 Mar 9;18(1):30. doi: 10.1186/s13058-016-0687-3.

4.

Glucose is a key driver for GLUT1-mediated nanoparticles internalization in breast cancer cells.

Venturelli L, Nappini S, Bulfoni M, Gianfranceschi G, Dal Zilio S, Coceano G, Del Ben F, Turetta M, Scoles G, Vaccari L, Cesselli D, Cojoc D.

Sci Rep. 2016 Feb 22;6:21629. doi: 10.1038/srep21629.

Supplemental Content

Loading ...
Support Center